Abstract:The isolation and detection of rare circulating tumor cells (CTCs) from patient peripheral blood can help early diagnosis of cancer and evaluation of therapeutic outcomes. At present, most of the available strategies for enriching CTCs face serious problems with purity due to the nonspecific interactions between the capture medium and leukocytes. Inspired by the immune evasion ability of homologous red blood cells (RBCs), we modified the tumor-targeting molecule folic acid (FA) on the surface of RBCs by hydrophobic interactions. Under the treatment of polybrene, the charges on the surface of RBCs are neutralized, which reduces the mutual repulsion force. Furthermore, RBCs treated with polyethylene also have excellent deformability, thereby enabling engineered RBCs to form a dense bionic layer on the adhesive glass slide, which can greatly inhibit the nonspecific adhesion of leukocytes. The bionic layer can achieve high-purity enrichment of tumor cells in phosphate-buffered saline (PBS), and we can achieve high-activity release in plasma. The cell count showed over 80% capture efficiency and over 70% release rate, and the purity of CTCs obtained in the artificial blood sample after release was higher than 90%. The RBC bionic surface coating is notably cost-effective and highly applicable for CTC isolation in clinic practice, and thus provides new prospects for designing cell–material interfaces for advanced cell-based biomedical studies in the future.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c05806?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c05806</a>.Process and details of the formation of the bionic layer (Movie S1) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c05806/suppl_file/am1c05806_si_001.mp4">MP4</a>)(Movie S2) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c05806/suppl_file/am1c05806_si_002.mp4">MP4</a>)Clinical patients' blood sample information; the morphology of red blood cells gradually changes, as the amount of DSPE-PEG-FA modification increases; the bionic layer is prepared by using red blood cells that have not been treated with polybrene; the picture of bionic layer prepared by DSPE-PEG-FITC modified red blood cells, the picture was taken under bright-field and fluorescent light; fluorescence photographs of the bionic layer capture (left) and release cells (right); information about colon cancer (C) patients and healthy donors (H) enrolled in our work (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c05806/suppl_file/am1c05806_si_003.pdf">PDF</a>)This article has not yet been cited by other publications.

New Insights into Red Blood Cells in Tumor Precision Diagnosis and Treatment

New Role of Red Blood Cells in Absorption of DNA Bearing Tumorigenic Mutations from Lung Cancer Tissue

Mature Red Blood Cells Contain Long DNA Fragments and Could Acquire DNA from Lung Cancer Tissue

The functional and clinical roles of liquid biopsy in patient-derived models

Red blood cell-tumour cell interactions promote tumour cell progression

Red Blood Cell-Derived Exosomal Oncogenic MicroRNA Promote Cancer Development and Progression

Red blood cells based nanotheranostics: A smart biomimetic approach for fighting against cancer

Tumor-Educated Platelet RNA and Circulating Free RNA: Emerging Liquid Biopsy Markers for Different Tumor Types

Biomimetic Nanocatalysts Enhance Oxidative Damage Against Cancer Cells

Red Blood Cell-Mimic Nanocatalyst Triggering Radical Storm to Augment Cancer Immunotherapy.

Circulating Tumor Cells in Precision Oncology: Clinical Applications in Liquid Biopsy and 3D Organoid Model

Emerging Microfluidic Technologies for the Detection of Circulating Tumor Cells and Fetal Nucleated Red Blood Cells

Ultradense Erythrocyte Bionic Layer Used to Capture Circulating Tumor Cells and Plasma-Assisted High-Purity Release

Circulating tumor cells and DNA as liquid biopsies

Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications

Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application

Circulating and Disseminated Tumor Cells: Diagnostic Tools and Therapeutic Targets in Motion

Early Detection, Precision Treatment, Recurrence Monitoring: Liquid Biopsy Transforms Colorectal Cancer Therapy

Red Blood Cell–derived Nanoerythrosome for Antigen Delivery with Enhanced Cancer Immunotherapy

Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression Monitoring.

Physiologically triggered injectable red blood cell-based gel for tumor photoablation and enhanced cancer immunotherapy